<DOC>
	<DOC>NCT03054636</DOC>
	<brief_summary>The Short term Perfusion Angiography (SPA) study is designed to collect 2D Perfusion data from Critical Limb Ischemia (CLI) endovascular (interventional) procedures for information on device performance in a real-world setting.</brief_summary>
	<brief_title>Short-term Perfusion Angiography Pilot Study (SPA)</brief_title>
	<detailed_description>This clinical study is designed to collect pre and post procedural imaging data using 2D Perfusion (2DP) software in patients receiving an endovascular intervention.</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1. Subject is &gt;18 years of age. 2. Subject or their legally authorized representative understands the research nature of the study and is willing and capable of providing informed consent 3. Subject has appropriate femoral arterial access 4. Subject presents with a Rutherford classification of 4 to 6. 5. Subject is scheduled for Digital Subtraction Angiography (DSA) with endovascular intervention below the knee on one or both limbs. 1. Subject is unwilling or unable to comply with the protocol including all followup visits 2. Critical limb ischemia due to acute arterial occlusion. 3. Subject unwilling or unable to comply with the protocol 4. Subjects with history of or known reaction or sensitivity to contrast agent that cannot be premedicated or any other condition that precludes an endovascular intervention and DSA 5. Female subject of childbearing potential who is pregnant (she must have negative pregnancy test within the 48 hours prior to enrollment), or plans a pregnancy during study period, 6. Subject life expectancy &lt; 3 months, 7. Subject is participating in a potentially confounding device or drug clinical trial that interferes with this study 8. Investigator considers subject to be a poor candidate for the study or believes that the patient may compromise the study, e.g., concomitant conditions (reasons will be documented)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>